Parmax Pharma Ltd manufactures bulk drugs, drugs intermediates, and specialty chemicalsBusiness Overview: Company used to do manufacturing bulk drugs and specialty chemicals but it discontinued its business activities for a few years. It deals in active pharmaceutical ingredients and Contract Manufacturing Operations. It plans to extend its activity to the...
Newspaper Publication for 32nd Annual general Meeting of the Company
Annual Report of Financial Year 2025-26 along with Notice of Annual General Meeting
Parmax Pharma's board has approved a preferential issue, allotting 31.37 lakh fully paid-up equity shares at Rs. 36.50 each to non-promoter investors, raising Rs. 11.45 Crore. Additionally, 21.45 lakh convertible warrants were allotted at Rs. 36.50 each to non-promoter investors, convertible into equity shares within 18 months. This capital raise...
Parmax Pharma has announced a significant shift in its ownership structure. Following an Open Offer and a Share Purchase Agreement, a new group of individuals will be classified as Promoters and members of the Promoter Group. The previous promoters, who sold 1,152,450 Equity Shares, representing 30.80% of the company's capital,...
